Pe­ter Thiel's Palan­tir scores con­tract with the FDA to speed up reg­u­la­to­ry re­views as de­lays keep grow­ing

Pe­ter Thiel, the bil­lion­aire lib­er­tar­i­an who qui­et­ly backed away in 2020 from his once-ar­dent sup­port of Pres­i­dent Don­ald Trump, is no stranger to gov­ern­ment con­tracts. His com­pa­ny Palan­tir has se­cured dozens of con­tracts with the feds and now has an­oth­er big fish on the hook.

Palan­tir, the Den­ver-based da­ta and an­a­lyt­ics com­pa­ny Thiel co-found­ed in 2003, en­tered in­to an agree­ment this week with the FDA as the gov­ern­ment agency strug­gles to keep up with a surge of reg­u­la­to­ry ap­proval needs due to the Covid-19 pan­dem­ic.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER